Mingtao Liu | Genetic Epidemiology | Best Researcher Award

Dr. Mingtao Liu | Genetic Epidemiology | Best Researcher Award

First Affiliated Hospital of Guangzhou Medical University, Guangzhou | China

Author Profile

Scopus

Orcid ID

Google Scholar

🧬 Mingtao Liu: Emerging Innovator in Respiratory Medicine and Immunity Research 🧬

EARLY ACADEMIC PURSUITS 📚

Mingtao Liu began his academic journey with a B.Sc. in Forensic Science at Guangdong Medical University (2016–2021). During these years, he developed a foundation in analytical skills and scientific investigation, which later fueled his passion for medical research. Following his undergraduate studies, he pursued an M.Sc. in Clinical Laboratory Diagnostics at Guangzhou Medical University (2021–2024), where he focused on laboratory techniques essential to clinical medicine. This period not only honed his skills in diagnostics but also set the stage for his Ph.D. studies in Respiratory Medicine, emphasizing clinical applications and research into respiratory health.

PROFESSIONAL ENDEAVORS 🏆

Currently a Ph.D. candidate at Guangzhou Medical University, Mingtao specializes in respiratory medicine, with his research spanning diagnostic and prognostic biomarkers, particularly in allergic immunity. His work in multi-omics approaches to studying lung inflammation and tumor effects showcases his commitment to unraveling the molecular complexities of respiratory diseases. Mingtao’s technical skills in machine learning, data analysis, and programming languages such as Matlab and Python have empowered him to engage in cutting-edge research, particularly in big data mining and epidemiological investigation.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETIC EPIDEMIOLOGY🔍

Mingtao’s research contributions are centered on:

  1. Respiratory Immunity: He investigates diagnostic and prognostic biomarkers of respiratory immunity, focusing on allergic responses, a critical area in respiratory health.
  2. Multi-Omics Analysis: His work integrates genomics, proteomics, and metabolomics to explore mechanisms of lung inflammation and tumor development.
  3. LDT and IVD Kits: Mingtao is involved in the development of laboratory-developed tests (LDT) and in vitro diagnostic (IVD) kits based on liquid chromatography–mass spectrometry (LC-MS), providing innovative solutions for clinical diagnostics.
  4. Big Data and Epidemiology: Through epidemiological research and data mining, he is advancing our understanding of respiratory disease prevalence and risk factors.

IMPACT AND INFLUENCE 🌐

Mingtao Liu’s work has garnered recognition for its relevance and potential impact on public health. He has received notable accolades, including the European Respiratory Society 2023 Excellent Young Paper Scholarship, the National Scholarship (2023), and the Outstanding Graduate Scholarship (2024). His research contributes significantly to the development of diagnostic tools and methodologies that can potentially reshape how respiratory diseases are detected and managed, especially in the area of allergic immunity.

ACADEMIC CITES 📈

As a young researcher, Mingtao has begun building his academic footprint. His contributions are starting to be cited in relevant fields, particularly those related to respiratory medicine, allergy research, and clinical diagnostics. This early recognition in academic circles signals his growing influence as a researcher.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

Mingtao Liu’s research focus aligns with global health priorities, positioning him to make lasting contributions to the fields of respiratory health and immunology. His work on biomarkers and diagnostic kits is paving the way for more accurate, accessible, and individualized approaches to respiratory healthcare. Looking ahead, Mingtao aspires to continue his research and potentially expand into translational medicine, applying his findings to develop practical healthcare solutions that benefit patients worldwide.

ADDITIONAL TOPICS 📝

  • TECHNICAL PROFICIENCY: Mingtao possesses advanced skills in machine learning, data analysis, and programming (Python, Matlab), as well as fluency in English, Chinese, and Cantonese. These competencies enhance his ability to engage in complex research and communicate his findings to a broad audience.
  • AWARDS AND RECOGNITION: Mingtao’s scholarship awards affirm his dedication to excellence in research and academics. The European Respiratory Society award, in particular, highlights his promise as a leading voice in respiratory medicine.

NOTABLE PUBLICATIONS 📑

"Novel prediction model of early screening lung adenocarcinoma with pulmonary fibrosis based on haematological index

  • Authors: Li, H. , Fu, X. , Liu, M. , Cheng, Z.J. , Sun, B.
  • Journal: BMC Cancer
  • Year: 2024

"Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia

  • Authors: Cheng, Z.J. , Li, H. , Liu, M. , Gan, H. , Sun, B.
  • Journal: BMC Cancer
  • Year: 2024

"Interpreting epidemiologic distribution of total and specific IgE levels for food allergy in Southern China from 2004 to 2023: understanding the mechanisms and focusing on prevention

  • Authors: Liu, M. , Liu, L. , Qi, W. , Huang, H. , Sun, B.
  • Journal: BMC public health
  • Year: 2024

"Decoding acute myocarditis in patients with COVID-19: Early detection through machine learning and hematological indices

  • Authors: Li, H. , Cheng, Z.J. , Fu, X. , Wang, F. , Sun, B.
  • Journal: iScience
  • Year: 2014

"A Pilot HRCT Follow-Up Study to Test the Feasibility of Predictive Efficacy of Serum Periostin in Idiopathic Pulmonary Fibrosis

  • Authors: Liu, M. , Cheng, Z.J. , Chen, J. , Huang, H. , Sun, B.
  • Journal: Journal of Inflammation Research
  • Year: 2024

Youxin Wang | Epidemiology | Best Researcher Award 

Prof Youxin Wang | Epidemiology | Best Researcher Award 

North China University of Science and Technology | China

Author Profile

Scopus

Orcid ID

📚 YOUXIN WANG: A TRAILBLAZER IN PUBLIC HEALTH AND EPIDEMIOLOGY

EARLY ACADEMIC PURSUITS 🎓

Youxin Wang began her distinguished academic journey at the University of the Chinese Academy of Sciences, where she pursued a Ph.D. in Chemistry and Molecular Biology from 2005 to 2008. Her foundational training in this highly interdisciplinary field laid the groundwork for her future endeavors in public health, epidemiology, and health statistics. This early academic excellence positioned her as a versatile researcher capable of bridging molecular sciences with public health concerns.

PROFESSIONAL ENDEAVORS 👩‍🏫

Youxin Wang has held several prestigious positions, marking her steady ascent through academia:

  • Professor at the North China University of Science and Technology (2023 - Present): Currently, she holds the position of Professor at the School of Public Health, where she continues to expand her research and influence.
  • Professor at Capital Medical University (2019 - 2022): At the Department of Epidemiology and Health Statistics, she contributed to key public health initiatives and academic research.
  • Associate Professor at Capital Medical University (2014 - 2018): During this time, Wang honed her skills in teaching and mentoring the next generation of health professionals.
  • Lecturer at Capital Medical University (2008 - 2013): Her initial role at the same institution, where she laid the foundation of her teaching and research career.

CONTRIBUTIONS AND RESEARCH FOCUS ON EPIDEMIOLOGY🔬

Youxin Wang's research has focused on epidemiology, particularly in the fields of health statistics and the intersection of molecular biology and public health. She received funding from the National Natural Science Foundation of China for her groundbreaking project, Significance of Plasma N-glycome in Predicting Type 2 Diabetes and the Glycome-Genome Association Study (2014 - 2017). This research aimed to better understand the genomic predictors of diabetes, offering valuable insights for early diagnosis and treatment.

IMPACT AND INFLUENCE 🌍

Throughout her career, Youxin Wang has contributed to significant developments in public health, particularly in epidemiological methods and the study of chronic diseases like diabetes. Her role as an Adjunct Professor at Edith Cowan University (2020 - Present) reflects her international influence and collaborative efforts in advancing global health research. She has mentored students and professionals, shaping the future of public health research.

ACADEMIC CITES AND RECOGNITION 🏆

With a robust publication record and numerous citations, Youxin Wang’s work has been recognized both in China and internationally. Her innovative research on the plasma N-glycome and its role in diabetes prediction has garnered significant attention in epidemiological and biochemical research circles.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Youxin Wang's lasting legacy lies in her integrative approach to public health, combining molecular biology with epidemiology to address real-world health issues. As she continues her professorship at North China University of Science and Technology, she is poised to make further advancements in public health, with a focus on chronic disease prediction and prevention. Her ongoing research and mentorship will undoubtedly continue to influence both the scientific community and healthcare systems worldwide.

NOTABLE PUBLICATIONS 📑

"Associations of metabolic changes and polygenic risk scores with cardiovascular outcomes and all-cause mortality across BMI categories: a prospective cohort study" 

  • Authors: Li, C. , Meng, X. , Zhang, J. , Sun, S. , Wang, Y.
  • Journal: Cardiovascular Diabetology
  • Year: 2024

"Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations" 

  • Authors: Liu, D. , Cao, M. , Wang, H. , Li, Y. , Wang, Y.
  • Journal: BMC Medicine
  • Year: 2024

"Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study)" 

  • Authors: Zhang, P.-P. , Wang, Y.-X. , Shen, F.-J. , Wang, H. , Li, L.
  • Journal: Trials
  • Year: 2024

"Potentially causal association between immunoglobulin G N-glycans and cardiometabolic diseases: Bidirectional two-sample Mendelian randomization study" 

  • Authors: Meng, X. , Liu, D. , Cao, M. , Wang, W. , Wang, Y.
  • Journal: International Journal of Biological Macromolecules
  • Year: 2024

"Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6–14 years in China and its applications in high-obesity-risk countries and regions" 

  • Authors: Liu, Y. , Wang, Y. , Xing, Y. , Wang, H. , Song, Y.
  • Journal: The Lancet Regional Health - Western Pacific
  • Year: 2024